Are GLP-1 drugs prescribed for weight loss becoming too outsized a line item for continued coverage through the state ...
Insurers cite unsustainable costs as GLP-1 benefits disappear, accelerating a national shift in employer-sponsored ...
(CNN)– The Food and Drug Administration (FDA) wants suicide warnings to be taken off of some popular weight-loss medications.
You can switch from Ozempic® to another medication, but you’ll likely need to start on a low dose of the new medication. Ozempic® is a diabetes drug from the pharmaceutical manufacturer Novo Nordisk.
By Mariam Sunny Jan 13 (Reuters) - The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential ...
This article was reviewed by Lynn Marie Morski, MD, JD Key Takeaways: Peptides are compounds made of amino acids linked by ...
A drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined with diet and exercise, a small new study shows. Liraglutide lowered body mass, ...
The Food and Drug Administration (FDA) is seeking to remove suicide warnings from several popular weight-loss medications, ...
US FDA review finds no evidence linking GLP-1 receptor agonists in popular medicines like Wegovy and Zepbound to an increased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results